Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT02520440
Other study ID # NP 1769/2014
Secondary ID
Status Completed
Phase N/A
First received August 6, 2015
Last updated August 7, 2015
Start date September 2014
Est. completion date July 2015

Study information

Verified date August 2015
Source Azienda Ospedaliera Spedali Civili di Brescia
Contact n/a
Is FDA regulated No
Health authority Italy: Ethics CommitteeItaly: National Institute of Health
Study type Observational

Clinical Trial Summary

The gastrointestinal dysfunction occurs frequently during the intensive care unit (ICU) stay and is associated with a worse prognosis.

The gastrointestinal failure (GIF) is diagnosed based on symptoms such as bowel distension, ileus, diarrhea, digestive bleeding, or intestinal ischemia. A GIF score based on has been demonstrated to be correlated with outcome, with higher scores indicating higher risk of death. However, GIF may be occult or clinical signs can go undetected in critically ill patients due to the frequent use of analgesic, sedative or neuromuscular blocking agents, acute neurologic diseases, or delirium.

Citrulline is a potential biomarker for small bowel function in critically ill patients with maintained renal function. Normal plasma citrulline levels (12-55 µmol/L) are determined by the balance between gut synthesis and kidney degradation.

GIF is involved in the pathogenesis of multiple organ dysfunctions and failures (MOF) through various mechanisms, and it is often associated with high intra-abdominal pressure (IAP). IAP greater than 12 mmHg, may lead to abdominal compartment syndrome (ACS) and MOF, including cardiac, respiratory and kidney failure. Studies have suggested that GIF can be the consequence rather than the cause of MOF.

The aim of this study is to investigate if plasma citrulline levels is associated with a clinical diagnosis of GIF, and may predict the development of MOF.


Recruitment information / eligibility

Status Completed
Enrollment 42
Est. completion date July 2015
Est. primary completion date July 2015
Accepts healthy volunteers No
Gender Both
Age group 18 Years and older
Eligibility Inclusion Criteria:

- Intensive Care Unit stay of at least 48 hours

Exclusion Criteria:

- Intensive Care Unit stay less than 48 hours

- abdominal trauma or surgery in the last 6 weeks

- inflammatory bowel disease

- a body mass index (BMI) =35

- terminal condition.

Study Design

Observational Model: Cohort, Time Perspective: Prospective


Intervention

Biological:
Monitoring of plasmatic levels of Citrulline
Measured plasma amino-acids levels
Device:
Intra-abdominal pressure monitoring
Intra-abdominal Hypertension is defined as an average pressure of the day = 12 mmHg; abdominal compartment syndrome is defined as a sustained (minimally two standardized measurements, performed 1-6 h apart) increase in Intra-abdominal pressure above 20 mmHg with new onset organ failure.
Biological:
Monitoring of plasmatic levels of Arginine and Glutamine
Measured plasma amino-acids levels

Locations

Country Name City State
n/a

Sponsors (2)

Lead Sponsor Collaborator
Azienda Ospedaliera Spedali Civili di Brescia Università degli Studi di Brescia

References & Publications (6)

Carlson GL, Dark P. Acute intestinal failure. Curr Opin Crit Care. 2010 Aug;16(4):347-52. doi: 10.1097/MCC.0b013e328339fabe. Review. — View Citation

Malbrain ML, Cheatham ML, Kirkpatrick A, Sugrue M, Parr M, De Waele J, Balogh Z, Leppäniemi A, Olvera C, Ivatury R, D'Amours S, Wendon J, Hillman K, Johansson K, Kolkman K, Wilmer A. Results from the International Conference of Experts on Intra-abdominal Hypertension and Abdominal Compartment Syndrome. I. Definitions. Intensive Care Med. 2006 Nov;32(11):1722-32. Epub 2006 Sep 12. — View Citation

Piton G, Manzon C, Cypriani B, Carbonnel F, Capellier G. Acute intestinal failure in critically ill patients: is plasma citrulline the right marker? Intensive Care Med. 2011 Jun;37(6):911-7. doi: 10.1007/s00134-011-2172-x. Epub 2011 Mar 12. Review. — View Citation

Piton G, Manzon C, Monnet E, Cypriani B, Barbot O, Navellou JC, Carbonnel F, Capellier G. Plasma citrulline kinetics and prognostic value in critically ill patients. Intensive Care Med. 2010 Apr;36(4):702-6. doi: 10.1007/s00134-010-1751-6. — View Citation

Puleo F, Arvanitakis M, Van Gossum A, Preiser JC. Gut failure in the ICU. Semin Respir Crit Care Med. 2011 Oct;32(5):626-38. doi: 10.1055/s-0031-1287871. Epub 2011 Oct 11. Review. — View Citation

Reintam A, Parm P, Kitus R, Starkopf J, Kern H. Gastrointestinal failure score in critically ill patients: a prospective observational study. Crit Care. 2008;12(4):R90. doi: 10.1186/cc6958. Epub 2008 Jul 14. Erratum in: Crit Care. 2008;12(6):435. — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary Development of Gastro Intestinal Failure, defined as the presence of three or more gastro-intestinal symptoms; and Multiple Organ Failure measured by SOFA score to investigate if plasma citrulline levels are associated with a clinical diagnosis of Gastro Intestinal Failure, and may predict the development of Multiple Organ Failure. Gastrointestinal Failure is defined as the presence of three or more coincident GI symptoms (igh gastric residual volumes (GRV) = maximum GRV above 500 ml at least once. Absent bowel sounds (BS) = BS not heard on careful auscultation. Vomiting/Regurgitation= visible vomiting or regurgitation in any amount. Diarrhoea = loose of liquid stool three or more times per day. Bowel distension= suspected or radiologically confirmed bowel dilatation in any bowel segment. GI bleeding= visible appearance of blood in vomit, nasogastric aspirate or stool.). MOF was defined as the failure of two or more organs or system according to the Sequential Organ Failure Assessment (SOFA) within the first 30 days after admission in intensive care unit Yes
Secondary Correlation between intra abdominal hypertension (defined as an average of intra-abdominal pressure of the day = 12 mmHg), and development of Gastro Intestinal Failure and Multiple Organ Failure to investigate if increasing of intra abdominal pressure is associated with a clinical diagnosis of Gastro Intestinal Failure, and may predict the development of Multiple Organ Failure. Intra-abdominal Hypertension (IAH) is defined as an average IAP of the day = 12 mmHg; abdominal compartment syndrome (ACS) is defined as a sustained (minimally two standardized measurements, performed 1-6 h apart) increase in IAP above 20 mmHg with new onset organ failure. within the first 30 days after admission in intensive care unit Yes
Secondary Correlation between levels of Arginine and Glutamine in patients with Gastro Intestinal Failure and Multiple Organ Failure to investigate if plasma Arginine and Glutamine levels are associated with a clinical diagnosis of Gastro Intestinal Failure, and may predict the development of Multiple Organ Failure. within the first 30 days after admission in intensive care unit Yes
See also
  Status Clinical Trial Phase
Recruiting NCT04695119 - Sepsis in the ICU-II
Not yet recruiting NCT05872152 - Impact of Fourier Transform Infrared Spectroscopy (FTIRS) in ICUs N/A
Not yet recruiting NCT04502511 - Heterogeneity of Critical Illness: a Cohort Study
Recruiting NCT03825250 - The Val-CARD Trial Phase 1/Phase 2
Completed NCT03344627 - Clinical Outcome Study of High-dose Meropenem in Sepsis and Septic Shock Patients N/A
Completed NCT04772703 - DNA Damage in Critically Ill COVID-19 Patients
Recruiting NCT06452966 - The Impact and Effect of Traditional Chinese Medicine Treatment on Organ Failure in Critically Ill Patients N/A
Recruiting NCT04015973 - The PRE-OP ENERGY Trial N/A
Withdrawn NCT03933930 - Comparing the Prognosis of Lactate-directed and Goal-directed Therapy in Hyperthermic Intraperitoneal Chemotherapy. N/A
Completed NCT03075605 - PROOF: Pancreatitis-associated Risk Of Organ Failure
Not yet recruiting NCT06330610 - Evaluation of the Efficiency of Intermittent Enteral Nutrition on Multi-organ Failure From Patients With Mechanical Ventilation in Intensive Care Unit N/A
Recruiting NCT03547232 - Rectal Indomethacin as Early Treatment for Acute Pancreatitis (INDOMAP Trial) Phase 4
Not yet recruiting NCT03282253 - Elevated Stearoyl-CoA Desaturase-1 Expression Predicts the Disease Severity of Severe Acute Pancreatitis N/A
Completed NCT05972980 - Ventilator-Associated Pneumonia in Critically Ill COVID-19 vs. Non-COVID-19 Patients
Withdrawn NCT03167788 - Red Cell Rejuvenation for the Attenuation of Transfusion Associated Organ Injury in Cardiac Surgery Phase 2
Recruiting NCT05405426 - Trial of Indication-Based Transfusion of Red Blood Cells in ECMO N/A
Completed NCT04732481 - Evaluation of Corrected Carotid Flow Time Variations During Passive Leg Lift to Predict Response to Filling.